FITC Anti-Human CD61 Antibody[VI-PL2]

The FITC Anti-Human CD61 Antibody [VI-PL2] is a highly specific and sensitive monoclonal antibody that has been designed for use in a variety of research applications. This antibody is specifically designed to target the human CD61 antigen, which is also known as integrin beta-3. The CD61 antigen is a transmembrane glycoprotein that is expressed on the surface of platelets, megakaryocytes, and endothelial cells.

The FITC Anti-Human CD61 Antibody [VI-PL2] has been conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of the CD61 antigen in a variety of experimental settings. This antibody has been extensively validated for use in flow cytometry, immunofluorescence microscopy, and other immunological assays.

The FITC Anti-Human CD61 Antibody [VI-PL2] has been rigorously tested for specificity and sensitivity, ensuring that it provides reliable and reproducible results. This antibody has been shown to exhibit minimal cross-reactivity with other antigens, making it an ideal choice for use in complex biological samples.

This antibody is supplied in a convenient and easy-to-use format, with a concentration of 0.5 mg/mL. It is recommended for use at a dilution of 1:100 for flow cytometry and 1:50 for immunofluorescence microscopy. This antibody is suitable for use in a variety of research applications, including studies of platelet function, thrombosis, and angiogenesis.

Overall, the FITC Anti-Human CD61 Antibody [VI-PL2] is a highly specific and sensitive tool for the detection and analysis of the CD61 antigen in human samples. Its high quality and reliability make it an essential tool for researchers in the fields of immunology, hematology, and vascular biology.